Predicting analysis times in randomized clinical trials with cancer immunotherapy. [electronic resource]
Producer: 20161017Description: 12 p. digitalISSN:- 1471-2288
- Algorithms
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials, Phase III as Topic -- methods
- Dacarbazine -- administration & dosage
- Humans
- Immunotherapy -- methods
- Ipilimumab
- Kaplan-Meier Estimate
- Melanoma -- drug therapy
- Models, Theoretical
- Neoplasms -- immunology
- Outcome Assessment, Health Care -- methods
- Prognosis
- Randomized Controlled Trials as Topic -- methods
- Reproducibility of Results
- Research Design
- Retrospective Studies
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.